Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. (Q48857077)

16 February 2018

title

Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. (English)

1 reference

16 February 2018

6

Christophe Lancon

1 reference

16 February 2018

Raphaëlle Richieri

1

object named as

Raphaelle Richieri

1 reference

16 February 2018

author name string

Laurent Boyer

2

1 reference

16 February 2018

Jean Farisse

3

1 reference

16 February 2018

Cecile Colavolpe

4

1 reference

16 February 2018

Olivier Mundler

5

1 reference

16 February 2018

Eric Guedj

7

1 reference

16 February 2018

publication date

7 June 2011

1 reference

16 February 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

16 February 2018

volume

38

1 reference

16 February 2018

page(s)

1715-1722

1 reference

16 February 2018

issue

9

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-011-1850-9

exact match

0 references

cites work

Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Patients' perspectives on electroconvulsive therapy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Frontocingulate dysfunction in depression: toward biomarkers of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Limbic-frontal circuitry in major depression: a path modeling metanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Cingulate function in depression: a potential predictor of treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Transcranial magnetic stimulation in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

Comparison of "standard" and "navigated" procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

A Randomized, Controlled Trial With 6-Month Follow-Up of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Severe Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1850-9

[French adaptation, concurrent validation and factorial analysis of the Bech and Rafaelsen melancholia scale]

21 January 2018

1 reference

12 December 2020

Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).

1 reference

12 December 2020

Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism

1 reference

12 December 2020

An inventory for measuring clinical anxiety: psychometric properties

1 reference

12 December 2020

Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.

1 reference

12 December 2020

[The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlöcher's retardation scale]

1 reference

12 December 2020

Factorial structure of the Hamilton depression scale. I

1 reference

12 December 2020

Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial

1 reference

12 December 2020

[New validation of the Montgomery and Asberg Depression Scale (MADRS) on a sample of 147 hospitalized depressed patients]

1 reference

12 December 2020

Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability.

1 reference

12 December 2020

Study of Beck's hopelessness scale. Validation and factor analysis

1 reference

12 December 2020

A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression

1 reference

12 December 2020

Efficacité de la stimulation magnétique transcrânienne (rTMS) dans le traitement de la dépression : revue de la littérature

1 reference

12 December 2020

Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression

1 reference

12 December 2020

Factorial analysis of the Hamilton depression scale, II

1 reference

12 December 2020

Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS

1 reference

12 December 2020

10.1007/S00259-011-1850-9

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

21647787

1 reference

16 February 2018